- Net loss widened to $2.33M vs. $1.73M in the prior-year period
- Total assets declined to $1.31M while total liabilities climbed to $2.51M
- R&D reduced to $0.2M amid pending merger activities
Bearish AI Sentiment (-4.5 / 10)
Signal #119991 · SEC 8-K
$INM SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $INM filing catalyst
Why did $INM trigger an AI stock catalyst alert?
$INM triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: -4.5/10). Headline: InMed Pharmaceuticals Reports Q1 Loss Expansion to $2.33M as Liabilities Exceed Assets. Key points: - Net loss widened to $2.33M vs. $1.73M in the prior-year period - Total assets declined to $1.31M while total liabilities climbed to $2.51M - R&D reduced to $0.2M amid pending merger activities
How did $INM stock react after the SEC filing?
After the SEC 8-K for $INM, observed market reaction: T0 price $1.68. Past moves do not guarantee future results.
Where can I get real-time $INM SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $INM via Telegram and the VIP Web Terminal from €10/month.